These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3558853)

  • 1. Stimulus control of anticipatory nausea in cancer chemotherapy.
    Greene PG; Seime RJ
    J Behav Ther Exp Psychiatry; 1987 Mar; 18(1):61-4. PubMed ID: 3558853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental analysis of classically conditioned nausea during cancer chemotherapy.
    Bovbjerg DH; Redd WH; Jacobsen PB; Manne SL; Taylor KL; Surbone A; Crown JP; Norton L; Gilewski TA; Hudis CA
    Psychosom Med; 1992; 54(6):623-37. PubMed ID: 1454956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.
    Fredrikson M; Fürst CJ; Lekander M; Rotstein S; Blomgren H
    Brain Behav Immun; 1993 Mar; 7(1):79-90. PubMed ID: 8471800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tastes associated with parenteral chemotherapy for breast cancer.
    Fetting JH; Wilcox PM; Sheidler VR; Enterline JP; Donehower RC; Grochow LB
    Cancer Treat Rep; 1985 Nov; 69(11):1249-51. PubMed ID: 3841501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity.
    Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
    Ann Behav Med; 2007 Feb; 33(1):69-79. PubMed ID: 17291172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of emesis in outpatients on chemotherapy for breast cancer and the clinical efficacy of ondansetron hydrochloride tablets].
    Ishida T; Kusaba T; Hayakawa H
    Gan To Kagaku Ryoho; 2002 May; 29(5):723-8. PubMed ID: 12040676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].
    Domaradzka-Woźniak A; Wojtacki J; Dziewulska-Bokiniec A
    Przegl Lek; 1994; 51(5):203-5. PubMed ID: 7938648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned reactions to cancer chemotherapy: percent reinforcement predicts anticipatory nausea.
    Tomoyasu N; Bovbjerg DH; Jacobsen PB
    Physiol Behav; 1996 Feb; 59(2):273-6. PubMed ID: 8838605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticipatory nausea in cancer patients receiving chemotherapy: classical conditioning etiology and therapeutical implications.
    Stockhorst U; Klosterhalfen S; Klosterhalfen W; Winkelmann M; Steingrueber HJ
    Integr Physiol Behav Sci; 1993; 28(2):177-81. PubMed ID: 8318445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
    Wilcox PM; Fetting JH; Nettesheim KM; Abeloff MD
    Cancer Treat Rep; 1982 Aug; 66(8):1601-4. PubMed ID: 7049385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between PONV and chemotherapy-induced nausea and vomiting?
    Oddby-Muhrbeck E; Öbrink E; Eksborg S; Rotstein S; Lönnqvist PA
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):749-53. PubMed ID: 23281590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study.
    Roila F; Basurto C; Minotti V; Ballatori E; Tonato M; Del Favero A
    Oncology; 1988; 45(5):346-9. PubMed ID: 3412741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning.
    Bovbjerg DH
    Auton Neurosci; 2006 Oct; 129(1-2):92-8. PubMed ID: 16905371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
    Levitt M; Warr D; Yelle L; Rayner HL; Lofters WS; Perrault DJ; Wilson KS; Latreille J; Potvin M; Warner E
    N Engl J Med; 1993 Apr; 328(15):1081-4. PubMed ID: 8455665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipatory nausea and vomiting in an ambulatory medical oncology population.
    Fetting JH; Wilcox PM; Iwata BA; Criswell EL; Bosmajian LS; Sheidler VR
    Cancer Treat Rep; 1983 Dec; 67(12):1093-8. PubMed ID: 6652626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
    Aboud A; Buzdar AU; Yap HY; Hortobagyi GN; Blumenschein GR
    J Surg Oncol; 1984 Jul; 26(3):205-7. PubMed ID: 6610802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.
    Colleoni M; Price KN; Castiglione-Gertsch M; Gelber RD; Coates AS; Goldhirsch A
    Lancet; 1999 Jul; 354(9173):130-1. PubMed ID: 10408495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problem of local control in patients with advance breast cancer--a combined modality approach.
    Boyages J
    Australas Radiol; 1986 Feb; 30(1):60-2. PubMed ID: 3755336
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
    Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
    J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.